Bayer Group Consolidated Statements of Income

	2nd Quarter 2007	2nd Quarter 2008	1st Half 2007	1st Half 2008
€ million
Net sales	8,217	8,511	16,552	17,047
Cost of goods sold	(4,072)	(4,256)	(8,206)	(8,359)
Gross profit	4,145	4,255	8,346	8,688

Selling expenses	(1,919)	(2,034)	(3,726)	(3,936)
Research and development expenses	(650)	(648)	(1,275)	(1,281)
General administration expenses	(425)	(439)	(861)	(858)
Other operating income	228	563	371	850
Other operating expenses	(462)	(592)	(763)	(1,015)
Operating result [EBIT]	917	1,105	2,092	2,448

Equity-method loss	(13)	(13)	(27)	(23)
Non-operating income	190	161	432	289
Non-operating expenses	(434)	(410)	(880)	(803)
Non-operating result	(257)	(262)	(475)	(537)

Income before income taxes	660	843	1,617	1,911

Income taxes	(247)	(262)	(548)	(568)

Income from continuing operations after taxes	413	581	1,069	1,343

Income from discontinued operations after taxes	244	-	2,398	-

Income after taxes	657	581	3,467	1,343
of which attributable to minority interest	(3)	7	(2)	7
of which attributable to Bayer AG stockholders (net income)	660	574	3,469	1,336

Earnings per share (€)
From continuing operations
Basic*	0.53	0.73	1.36	1.69
Diluted*	0.53	0.73	1.36	1.69

From discontinued operations
Basic*	0.30	-	2.91	-
Diluted*	0.30	-	2.91	-

From continuing and discontinued operations
Basic*	0.83	0.73	4.27	1.69
Diluted*	0.83	0.73	4.27	1.69